Phase I single and multiple dose escalation trial of PRC 4016 in volunteers.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2012
At a glance
- Drugs Icosabutate (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Pharmacokinetics
- 14 Nov 2012 Status changed from recruiting to active, no longer recruiting based on information reported in a Pronova BioPharma media release
- 14 Nov 2012 The study will be finalised during the fourth quarter of 2012, according to a Pronova BioPharma media release.
- 19 Sep 2011 Status changed from planning to recruiting, according to a Pronova BioPharma media release.